The insider sales are routine and small relative to market cap, driven by option exercises and tax planning. No bearish signal. Monitor for any upcoming pipeline catalysts (Nurix is a clinical-stage biotech) that could move the stock independent of insider activity.
Price Chart
Executive Summary
Three C-suite insiders at Nurix Therapeutics (CFO, CSO, CLO) sold a total of ~$515K in open-market sales over a 7-day window, with the CLO's sale of $382K dominating the cluster. The sales are modest relative to the $2.4B market cap (~0.02%), and the CFO's and CSO's sales follow option exercises, suggesting tax/vesting-related liquidity rather than a bearish signal. The cluster is neutral given the small dollar amount and routine pattern of exercise-and-sell transactions.
Key Financial Metrics
Key Facts
- Three C-suite insiders (CFO, CSO, CLO) sold shares in open-market transactions totaling ~$515K.
- The largest sale was by CLO Christine Ring: 16,589 shares at $23.05 for $382K on 2026-08-03.
- CFO Hans van Houte sold 2,967 shares at $24.65 and 1,794 shares at $23.89, totaling ~$116K.
- CSO Gwenn Hansen sold 3,847 shares at $23.38 for ~$90K on 2026-07-30.
- All three insiders also exercised stock options (non-cash) on 2026-07-30, indicating the sales are likely for tax withholding or diversification.
- Total open-market sales represent ~0.02% of NRIX's $2.4B market cap — trivial in proportion.
Financial Impact
Total open-market insider sales of ~$515K, representing ~0.02% of market cap — immaterial.
Risk Factors
- Insider sales could accelerate if the stock continues to rise, but current pattern is non-informative.
- Clinical-stage biotech risk: any negative pipeline readout could overshadow insider activity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NRIX-1785894116182 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 29d ago | Insider Cluster | $25.32 $25.10 | ▼ −0.87% | ▲ +0.28% | $22.89 (−9.60%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.22 $27.19 | ▲ +7.81% | ▲ +6.60% | $22.89 (−9.24%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.89 (−8.88%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.89 (−8.88%) |
Aug 3, 2026 8w ago | Insider Cluster | $24.69 $25.96 | ▲ +5.14% | ▲ +5.24% | $22.89 (−7.29%) |
Jul 30, 2026 9w ago | Insider Cluster | $23.21 $25.53 | ▲ +10.00% | ▲ +6.48% | $22.89 (−1.38%) |
Jul 9, 2026 12w ago | Press Release | $23.06 $23.07 | ▲ +0.04% | ▲ +0.60% | $22.89 (−0.74%) |
Jul 2, 2026 13w ago | Insider Cluster | $23.97 $24.69 | ▲ +3.00% | ▲ +2.07% | $22.89 (−4.51%) |
Jun 11, 2026 16w ago | Institutional Cluster | $16.98 $17.12 | ▲ +0.82% | ▲ +0.39% | $22.89 (+34.81%) |
Jun 8, 2026 16w ago | 8-K | $15.64 $17.04 | ▲ +8.95% | ▲ +6.84% | $22.89 (+46.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access